150 related articles for article (PubMed ID: 7021422)
1. Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor.
Männel DN; Falk W; Meltzer MS
Infect Immun; 1981 Jul; 33(1):156-64. PubMed ID: 7021422
[TBL] [Abstract][Full Text] [Related]
2. Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).
Männel DN; Moore RN; Mergenhagen SE
Infect Immun; 1980 Nov; 30(2):523-30. PubMed ID: 7002801
[TBL] [Abstract][Full Text] [Related]
3. Tumoricidal effector mechanisms of murine BCG-activated macrophages. I. Parameters of production and initial characterization of a cytolytic factor serologically related to necrosin.
Klostergaard J; Foster WA; Leroux ME
J Biol Response Mod; 1987 Jun; 6(3):313-30. PubMed ID: 3298554
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
5. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
Falk LA; Hogan MM; Vogel SN
J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
Boraschi D; Meltzer MS
Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
[No Abstract] [Full Text] [Related]
8. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s).
Hibbs JB; Weinberg JB; Chapman HA
Adv Exp Med Biol; 1979; 121B():433-53. PubMed ID: 232620
[No Abstract] [Full Text] [Related]
10. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent.
Nascimento FR; Ribeiro-Dias F; Russo M
Braz J Med Biol Res; 1998 Dec; 31(12):1593-6. PubMed ID: 9951556
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on the tumour cytotoxicity of normal, stimulated and immunologically activated mouse macrophages.
Hansen JG; Bennedsen J; Rhodes JM; Larsen SO
Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):27-32. PubMed ID: 7080837
[TBL] [Abstract][Full Text] [Related]
13. In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate.
Weinberg JB
J Natl Cancer Inst; 1981 Mar; 66(3):529-33. PubMed ID: 6259399
[TBL] [Abstract][Full Text] [Related]
14. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
Boraschi D; Meltzer MS
J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
[No Abstract] [Full Text] [Related]
15. Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum.
Haidaris CG; Haynes JD; Meltzer MS; Allison AC
Infect Immun; 1983 Oct; 42(1):385-93. PubMed ID: 6352501
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.
Ruco LP; Meltzer MS; Rosenstreich DL
J Immunol; 1978 Aug; 121(2):543-8. PubMed ID: 681749
[No Abstract] [Full Text] [Related]
17. Correlation of macrophage-mediated tumor-cell lysis with the production of macrophage cytolytic factor (CF). Preliminary characterization of a factor inhibiting CF production.
Gifford GE; Loewenstein J; Yamin A; Gallily R
Int J Cancer; 1986 Jan; 37(1):73-9. PubMed ID: 3753597
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial activities of macrophages from C3H/HeN and C3H/HeJ mice treated with Mycobacterium bovis strain BCG.
Pappas MG; Nacy CA
Cell Immunol; 1983 Sep; 80(2):217-22. PubMed ID: 6349826
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli.
Ruco LP; Meltzer MS
Cell Immunol; 1978 Nov; 41(1):35-51. PubMed ID: 363288
[No Abstract] [Full Text] [Related]
20. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
Meltzer MS; Stevenson MM
J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
